Study guide
3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
Mississippi MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Mississippi MPJE Overview
1.1 Mississippi MPJE Format, Logistics & Official Blueprint 1.2 Study Strategy & Federal vs. Mississippi Legal Hierarchy 1.3 Federal & State Regulatory Authorities & Oversight
2 Chapter 2: Mississippi Pharmacy Governance, Board Structure & Licensure
2.1 Mississippi Board of Pharmacy: Structure, Authority & Operations 2.2 Pharmacist Licensure, Examination, Reciprocity & Continuing Education 2.3 Pharmacy Interns, Externs & Preceptor Requirements 2.4 Pharmacy Technicians: Registration, Scope & Supervision Ratios 2.5 Disciplinary Proceedings, Impairment & Current Monitoring
3 Chapter 3: Pharmacist Practice Standards & Prescribing Authority
3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS) 3.2 Prescriptive Authority in Mississippi: Physicians, Mid-Level Practitioners & Out-of-State 3.3 Collaborative Drug Therapy Management (CDTM) & Institutional Protocols 3.4 Patient Counseling, Prospective DUR & OBRA '90 Mandates 3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
4 Chapter 4: Controlled Substances: Scheduling, Ordering & Security
4.1 Federal & Mississippi Controlled Substance Scheduling 4.2 DEA Registration, Mississippi Permitting & Physical Security 4.3 Schedule II Ordering: Single-Sheet DEA Form 222 & Electronic CSOS 4.4 Controlled Substance Inventories: Mississippi Annual Mandate 4.5 Controlled Substance Disposal (DEA Form 41) & Theft/Loss Reporting Protocols
5 Chapter 5: Dispensing Controlled Substances & Prescription Processing
5.1 Schedule II Prescriptions: Issuance, Emergency Oral Dispensing & Sequential Prescriptions 5.2 Partial Filling of Controlled Substances: CARA, Out-of-Stock & Long-Term Care 5.3 Schedule III–V Prescriptions: Refill Limitations, Authorizations & Expirations 5.4 Prescription Transfers: Federal & Mississippi Requirements 5.5 Corresponding Responsibility, Red Flags & Legitimate Medical Purpose
6 Chapter 6: Mississippi Prescription Monitoring Program & Public Health Mandates
6.1 Mississippi Prescription Monitoring Program (MS PMP Gateway): Mandates & 24-Hour Reporting 6.2 Opioid Prescribing Limits, MME Calculations & Acute Pain Restrictions 6.3 Naloxone Standing Order, Overdose Prevention & Harm Reduction Dispensing 6.4 Behind-the-Counter Sales: Pseudoephedrine & Ephedrine Regulations 6.5 Pharmacist Immunization Authority & Protocol Administration in Mississippi
7 Chapter 7: Pharmacy Operations, Permits & Facilities
7.1 Community Pharmacy Permits, Pharmacist-in-Charge (PIC) Duties & Staffing 7.2 Institutional & Hospital Pharmacy Practice Regulations 7.3 Automated Medication Systems, Remote Dispensing & Telepharmacy 7.4 Non-Resident (Mail-Order) Pharmacies, Licensure & Wholesale Distributors 7.5 Drug Supply Chain Security Act (DSCSA), Track-and-Trace & Product Quarantines
8 Chapter 8: Compounding Standards, Safety & Product Selection
8.1 Non-Sterile Compounding (USP <795>): Categories, Beyond-Use Dating & Quality Assurance 8.2 Sterile Compounding (USP <797>): Cleanrooms, ISO Classifications & Aseptic Protocols 8.3 Hazardous Drug Handling (USP <800>): Engineering Controls, PPE & Spill Protocols 8.4 Generic Drug Substitution, FDA Orange Book & Purple Book Biosimilars 8.5 Repackaging, Unit-Dose Beyond-Use Dating & FDA Drug Recall Classifications
9 Chapter 9: Review, Clinical Scenarios & High-Yield Calculations
9.1 High-Yield Scenario Review: Resolving Complex Federal vs. Mississippi Legal Conflicts 9.2 Pharmacy Law Calculations: DEA Verification, Days Supply, Limits & Ratios 9.3 Rapid-Fire Master Review: Key Timelines, Quantities, Retention Periods & Forms 9.4 Exam Day Strategy, Computer-Adaptive Pacing & Distractor Elimination 9.5 High-Frequency MPJE Pitfalls & Distractor Traps
3.5 HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
Key Takeaways Explain This Topic AI
A pharmacy is a HIPAA covered entity when it transmits health information electronically in connection with an HHS-standard transaction; covered PHI may be written, electronic, or oral.
HIPAA permits authorization-free TPO disclosures and additional conditional pathways such as public health, health oversight, required-by-law, specified law-enforcement, and serious-threat disclosures.
The 'minimum necessary' standard requires limiting PHI disclosures to the least amount required to achieve the intended purpose, but does NOT apply to treatment-related communications between healthcare providers or disclosures mandated by law.
A covered direct-treatment pharmacy provides its Notice of Privacy Practices by first service delivery, makes a good-faith acknowledgment effort, retains required documentation for six years, and posts the notice as applicable.
Lawful exceptions permitting release of confidential pharmacy records without patient consent include Mississippi Board of Pharmacy inspectors, law enforcement executing a valid court order or subpoena, public health reporting, and the Mississippi Prescription Monitoring Program (MS PMP).
Last updated: August 2026
HIPAA, Patient Privacy & Confidentiality of Pharmacy Records
Patient confidentiality is both an ethical cornerstone and a strict legal mandate in pharmacy practice. The regulatory framework governing patient privacy comprises the federal Health Insurance Portability and Accountability Act of 1996 (HIPAA) ( 45 CFR Parts 160 and 164 ), the Health Information Technology for Economic and Clinical Health (HITECH) Act , and the Mississippi Pharmacy Practice Act (Miss. Code Ann. § 73-21-71 et seq.) along with Mississippi Board of Pharmacy regulations ( Miss. Admin. Code Title 30, Part 3001 ).
Under these authorities, pharmacists safeguard prescription records, patient profiles, and therapeutic information while applying the specific pathways under which disclosure is permitted or required. Confidentiality is the default, not an absolute bar to every disclosure.
1. Protected Health Information (PHI) & Covered Entity Status
A pharmacy is a HIPAA Covered Entity when it is a health care provider that transmits health information electronically in connection with a transaction for which HHS has adopted a standard. Individual pharmacists act through the covered entity; the job title alone is not the coverage test. Any third-party vendor that creates, receives, maintains, or transmits PHI on behalf of a pharmacy (e.g., cloud dispensing software vendors, claims clearinghouses, shredding services, pharmacy management platforms) is a Business Associate and must execute a formal, legally binding Business Associate Agreement (BAA) promising HIPAA-equivalent privacy safeguards.
Scope of Protected Health Information (PHI)
PHI is defined as any individually identifiable health information created or received by a covered entity that relates to:
- The past, present, or future physical or mental health or condition of an individual;
- The provision of healthcare to an individual; or
The past, present, or future payment for healthcare provided to an individual.
PHI is not limited to a checklist of 18 items. The familiar 18 identifier categories belong to HIPAA's safe-harbor de-identification method: removing those categories, together with the required lack of actual knowledge, can make information de-identified. Identifiable health information can be PHI even when a candidate cannot neatly assign it to one memorized category.
2. The TPO Framework: Permitted Disclosures Without Patient Authorization
Under the HIPAA Privacy Rule, a covered pharmacy may use and disclose PHI without obtaining a separate signed patient authorization for Treatment, Payment, and Health Care Operations (TPO) and for other pathways the rule specifically permits or requires, including appropriate public-health, health-oversight, required-by-law, law-enforcement, and serious-threat disclosures when their conditions are met. +-----------------------------------------------------------------------------+
- | THE HIPAA TPO DISCLOSURE FRAMEWORK |
- | |
- | [T - TREATMENT] |
- | - Dispensing medications, consulting with prescribers |
- | - Performing prospective DUR, reviewing drug interactions |
- | - Hospital discharge medication reconciliation, consulting specialists |
- | |
- | [P - PAYMENT] |
- | - Submitting electronic claims to PBMs and insurance plans |
- | - Processing prior authorizations, verifying patient insurance eligibility|
- | - Billing patients or third-party collection agencies for co-pays |
- | |
- | [O - OPERATIONS] |
- | - Internal quality assurance audits, medication error reviews |
- | - Training pharmacy interns, residents, and technician students |
- | - Regulatory compliance audits, accreditation surveys, business management|
- +-----------------------------------------------------------------------------+
- When an Authorization Is Required
A non-TPO use is not automatically prohibited. First ask whether another Privacy Rule permission or requirement applies. If none does, a valid written HIPAA authorization is generally required. Examples that ordinarily require authorization unless a specific exception applies include:
- Disclosing records to a patient's employer, life insurance company, or legal counsel;
- Marketing communications sponsored by pharmaceutical manufacturers;
- Selling pharmacy patient lists or prescription data to third-party marketing firms;
Research activities that do not meet formal Institutional Review Board (IRB) de-identification or waiver criteria.
3. The "Minimum Necessary" Standard & Key Exceptions
The Minimum Necessary Standard under 45 CFR § 164.502(b) mandates that when using, disclosing, or requesting PHI, a covered entity must make reasonable efforts to limit the information to the minimum amount necessary to accomplish the intended purpose. +-----------------------------------------------------------------------------+
- | THE MINIMUM NECESSARY RULE APPLICABILITY |
- | |
- | [MINIMUM NECESSARY APPLIES TO:] [MINIMUM NECESSARY DOES NOT APPLY:] |
- | - Insurance payment claims - Treatment disclosures between |
- | - Billing / collection queries healthcare providers (MD - RPh) |
- | - Quality assurance operational reviews- Disclosures directly to the |
- | - Non-routine legal disclosures patient upon request |
- | - Business associate service tasks - Disclosures authorized by patient |
- | - Disclosures mandated by law / DEA |
- +-----------------------------------------------------------------------------+
Important
Critical Exam Rule — Provider-to-Provider Treatment Exemption: When a pharmacist communicates with a physician, nurse practitioner, hospital discharge coordinator, or another pharmacist for the purpose of treating a patient , the minimum necessary rule does NOT apply. Providers are legally permitted to share comprehensive medical records to ensure optimal clinical decision-making.
4. Notice of Privacy Practices (NPP)
A covered pharmacy that has a direct treatment relationship must provide a Notice of Privacy Practices (NPP) explaining how it uses PHI, the individual's privacy rights, and the covered entity's legal duties.
Key NPP compliance mandates:
First Service Encounter: The pharmacy must provide the NPP to the patient on the date of first service delivery (e.g., when the first prescription is dispensed).
Good-Faith Effort for Written Acknowledgment: The pharmacy must make a good-faith effort to obtain a signed, written acknowledgment of receipt from the patient. If the patient refuses or cannot sign (e.g., emergency delivery), the pharmacist must document the good-faith effort and the reason why acknowledgment was not obtained .
Prominent Posting: The NPP must be posted in a clear, prominent location at the service site. If the covered provider maintains a website describing its services or benefits, the notice must also be available there.
Retention Schedule: Copies of the NPP, revisions, and signed patient acknowledgments must be retained for at least six (6) years from the date created or last in effect.
5. Lawful Disclosures Without Patient Consent: Regulatory & Legal Exceptions
Under federal HIPAA regulations and Mississippi Board rules, pharmacies are permitted—and in some cases legally compelled—to disclose confidential prescription records without patient authorization under specific circumstances:
Exception Category Authorized Entity Legal Prerequisites & Scope of Disclosure
Board of Pharmacy Investigations Mississippi Board of Pharmacy Inspectors & Compliance Officers Complete access to all pharmacy dispensing logs, controlled substance records, and prescription files during regulatory audits.
Law Enforcement Requests Police and other law-enforcement officials HIPAA permits specified disclosures under 45 CFR § 164.512(f), including qualifying legal process and limited requests or emergency circumstances. A badge and broad verbal demand alone do not establish a permitted disclosure; verify the exact legal basis and disclose only what the provision allows.
Prescription Monitoring Program Mississippi PMP (MS PMP Gateway) Mandatory 24-hour electronic reporting of all Schedule II–V controlled substance dispensing data ( Miss. Code Ann. § 73-21-127 ).
Public Health Reporting Mississippi State Department of Health (MSDH), CDC, FDA Disclosures authorized or required by the applicable public-health or abuse-reporting rule; verify the recipient, purpose, scope, and whether the report is mandatory or voluntary.
Emergency Medical Care Emergency Department Physicians, Paramedics Disclosing critical medication history to prevent imminent, serious harm or death to the patient when patient is incapacitated.
6. Patient Privacy Rights & Physical Safeguards
Under HIPAA, patients possess robust legal rights regarding their health information:
Right to Inspect and Copy: Patients have the right to inspect and obtain a paper or electronic copy of their PHI. The pharmacy must fulfill the request within 30 calendar days (with one allowable 30-day extension if written explanation is provided).
Right to Amend Records: Patients may request amendments to inaccurate or incomplete records; the pharmacy must respond within 60 days.
Right to an Accounting of Disclosures: Patients may request an accounting of the categories of disclosures covered by 45 CFR § 164.528 during the preceding 6 years ; the accounting rule has exclusions and is not shorthand for every non-TPO disclosure.
Physical and Technical Safeguards: Pharmacies must implement reasonable safeguards to avoid impermissible disclosures: maintaining private consultation areas, turning computer monitors away from waiting counters, keeping voices lowered during counseling, and using reasonable disposal safeguards for discarded prescription labels, leaflets, and vial caps, such as secure shredding or a qualified disposal service appropriate to the risk.